Skip to content
Directory

Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
19
currently held
Exits tracked
11
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital
Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital
Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital
Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin
Lauxera Capital Partners1 month ago

Board change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board

admin
Ardian1 month ago

Chairman update · Chairman update: du conseil de surveillance Thomas, Patrick · Chairman information updated

admin
PharmaUK
24 companies matching
VISUfarma
VISUfarma
GHO Capital Fund I LP
UK
Exited
Sector
Pharma
InvestorGHO Capital
Entry
2016
Hold
10yr
Exit
2026
to Lupin
Aenova
Aenova
BC European Capital IX
UK
Exited
Sector
Pharma
InvestorBC Partners
Entry
2005
Hold
12yr
Owners
2
Exit
2024
to Kuhne Holding
IPS Specials
Mezzanine II
UK
Active
Sector
Pharma
InvestorBeechbrook Capital
Entry
2010
Hold
12yr
Owners
2
Arcinova
Arcinova
BGF
UK
Exited
Sector
Pharma
InvestorBGF
Entry
2018
Hold
3yr
Exit
2021
to Quotient Sciences
Sygnature Discovery
Five Arrows Principal Investments
UK
Active
Sector
Pharma
InvestorFive Arrows Managers
Entry
2019
Hold
5yr
Owners
3
Cooper
CVC Capital Partners Fund VII
UK
Active
Sector
Pharma
InvestorCVC Capital Partners
Entry
2015
Hold
6yr
Owners
2
3.0x
Quotient Sciences
Permira VII
UK
Active
Sector
Pharma
InvestorPermira
Entry
2015
Hold
7yr
Owners
2
Quotient Clinical
GHO Capital Fund I LP
UK
Active
Sector
Pharma
InvestorGHO Capital
Entry
2013
Hold
11yr
Owners
2
AMCo
Cinven Fifth Fund
UK
Exited
Sector
Pharma
InvestorCinven
Entry
2012
Hold
3yr
Exit
2015
to Concordia Healthcare Corp.
Focus Pharmaceuticals
Mobeus VCTs
UK
Exited
Sector
Pharma
InvestorMobeus Equity Partners
Entry
2001
Hold
13yr
Exit
2014
to Amdipharm Mercury
Aston Particle Technologies
Aston Particle Technologies
DSW Ventures
UK
Active
Sector
Pharma
InvestorDSW Venture Capital
Entry
2022
Hold
4yr
CNX Therapeutics
CNX Therapeutics
Inflexion Continuation Fund I
UK
Active
Sector
Pharma
InvestorInflexion
Entry
2025
Hold
1yr
Ergomed
Ergomed
Permira VIII
UK
Active
Sector
Pharma
InvestorPermira
Entry
2023
Hold
3yr
Essential Pharma
Essential Pharma
Penta Capital Fund I
UK
Active
Sector
Pharma
InvestorPenta Capital
Entry
2025
Hold
1yr
Oxford Drug Design
Oxford Drug Design
Angel CoFund
UK
Active
Sector
Pharma
InvestorACF Investors
Entry
2019
Hold
7yr
Republic M
Republic M
Queen's Park Equity Partners I
UK
Active
Sector
Pharma
InvestorQueen's Park Equity
Entry
2022
Hold
4yr
Seda
Seda
BGF
UK
Active
Sector
Pharma
InvestorBGF
Entry
2025
Hold
1yr
Small Pharma
Small Pharma
Angel CoFund
UK
Active
Sector
Pharma
InvestorACF Investors
Entry
2017
Hold
9yr
Torbay Pharmaceuticals
Torbay Pharmaceuticals
NorthEdge Fund III
UK
Active
Sector
Pharma
InvestorNorthEdge Capital
Entry
2023
Hold
3yr
tranScrip
tranScrip
Palatine Impact Fund II
UK
Active
Sector
Pharma
InvestorPalatine Private Equity
Entry
2021
Hold
5yr
Kent Pharmaceuticals
DS Cornerstone Fund
UK
Active
Sector
Pharma
InvestorDuke Street
Entry
2019
Hold
7yr
Owners
2
EMAS Pharma
Kester Capital III
UK
Active
Sector
Pharma
InvestorKester Capital
Entry
2024
Hold
2yr
Rosemont Pharmaceuticals
Inflexion Continuation Fund I
UK
Active
Sector
Pharma
InvestorInflexion
Entry
2025
Hold
1yr
Sterling Pharma Solutions
GHO Capital Fund II LP
UK
Active
Sector
Pharma
InvestorGHO Capital
Entry
2019
Hold
7yr